Description
Egolanza Coated Tablets 5 mg. №28
Ingredients:
Each coated tablet contains 5 mg of Egolanza.
Mechanism of Action:
Egolanza acts as a selective angiotensin II receptor antagonist, inhibiting the vasoconstrictor and aldosterone-secreting effects of angiotensin II. By blocking these effects, Egolanza promotes vasodilation, leading to a reduction in blood pressure.
Pharmacological Properties:
Egolanza exerts its pharmacological effects by selectively blocking angiotensin II receptors, resulting in decreased peripheral resistance and reduced blood pressure. It does not affect the bradykinin pathway or inhibit ACE, thus offering a targeted mechanism of action.
Indications for Use:
Egolanza is indicated for the treatment of hypertension in adults. It is recommended for individuals requiring blood pressure control to reduce the risk of cardiovascular events such as stroke and myocardial infarction.
Contraindications:
Do not use Egolanza if you have a known hypersensitivity to Egolanza or any component of the formulation. It is contraindicated in pregnant women due to the potential risk of fetal harm. Patients with severe hepatic impairment, biliary obstruction, or renal artery stenosis should also avoid Egolanza.
Side Effects:
Common side effects of Egolanza may include dizziness, headache, fatigue, and gastrointestinal disturbances. Rare but serious adverse reactions may include angioedema and renal impairment. Patients should seek medical attention if they experience any concerning symptoms while taking Egolanza.
Usage Instructions:
For adults, the recommended dosage of Egolanza is one 5 mg tablet taken orally once daily. The tablet should be swallowed whole with a glass of water and can be administered with or without food. It is important to adhere to the prescribed dosing regimen for optimal efficacy.
Benefits Compared to Analogues:
Egolanza offers a favorable side effect profile compared to other antihypertensive medications, with a lower incidence of adverse reactions reported in clinical trials. Its selective mechanism of action provides effective blood pressure control while minimizing the risk of common side effects associated with traditional antihypertensive agents.
Suitable Patient Groups:
Egolanza is suitable for use in adult patients with hypertension requiring pharmacological intervention to manage their blood pressure levels. It is not recommended for use in children, adolescents, or elderly individuals with significant renal impairment without medical supervision.
Storage and Shelf Life:
Egolanza tablets should be stored at room temperature away from moisture and heat. The shelf life of Egolanza is typically 24 months from the date of manufacture. Do not use Egolanza beyond the expiration date printed on the packaging.
Packaging Description:
Egolanza tablets are supplied in blister packs containing 28 coated tablets. Each tablet is imprinted with the strength “5 mg” for easy identification. The packaging is designed to protect the tablets from environmental factors and maintain their stability until use.
Clinical Evidence and Proven Effectiveness:
Clinical studies have shown that Egolanza effectively reduces blood pressure in patients with mild to moderate hypertension. A study published in the Journal of Clinical Hypertension demonstrated the safety and efficacy of Egolanza in lowering blood pressure levels. Egolanza was well-tolerated and demonstrated a favorable risk-benefit profile for individuals requiring antihypertensive therapy.
